The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure

DOI10.1093/biostatistics/3.4.547zbMath1138.62354OpenAlexW2107399871WikidataQ47670957 ScholiaQ47670957MaRDI QIDQ5701166

Howard M. Sandler, Ngayee J. Law

Publication date: 2 November 2005

Published in: Biostatistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1093/biostatistics/3.4.547

zbMATH Keywords

Survival analysisMonte Carlo EMProstate cancerLongitudinal modelsCure modelsProstate specific antigen

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Monte Carlo methods (65C05) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02)

Related Items (21)

A stochastic model for prostate-specific antigen levels ⋮ Semiparametric Bayesian joint models of multivariate longitudinal and survival data ⋮ A new joint model for longitudinal and survival data with a cure fraction ⋮ Mixture cure rate models with neural network estimated nonparametric components ⋮ A characterization of missingness at random in a generalized shared-parameter joint modeling framework for longitudinal and time-to-event data, and sensitivity analysis ⋮ Joint modeling of longitudinal and time-to-event data on multivariate protein biomarkers ⋮ A stochastic model for PSA levels: behavior of solutions and population statistics ⋮ Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data ⋮ Estimation of reliability using failure-degradation data with explanatory variables ⋮ Analysis of joint multiple failure mode and linear degradation data with renewals ⋮ Semiparametric Modeling of Longitudinal Measurements and Time‐to‐Event Data–A Two‐Stage Regression Calibration Approach ⋮ Bayesian Influence Measures for Joint Models for Longitudinal and Survival Data ⋮ A Bayesian Semiparametric Survival Model with Longitudinal Markers ⋮ Bayesian Approaches to Joint Cure-Rate and Longitudinal Models with Applications to Cancer Vaccine Trials ⋮ Predictive comparison of joint longitudinal-survival modeling: a case study illustrating competing approaches ⋮ Random Changepoint Model for Joint Modeling of Cognitive Decline and Dementia ⋮ Assessing importance of biomarkers: A Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks ⋮ Analysis of longitudinal and survival data: joint modeling, inference methods, and issues ⋮ A Comparative Study of Approaches for Predicting Prostate Cancer from Longitudinal Data ⋮ Joint modeling of longitudinal and cure-survival data ⋮ A new approach for joint modelling of longitudinal measurements and survival times with a cure fraction

This page was built for publication: The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure